At-Home Gait Assessment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-11

Study Completion Date

2024-01-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to validate an MS Gait Remote Capture and Analysis (MS-GRCA) system based on wearable shoe-based motion sensors for home-based and repeatable gait assessments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device

NCT04969848

Multiple Sclerosis

COMPLETED

Assessment of Accelerometric Measurement Devices for Gait Analysis

NCT01522690

Healthy

COMPLETED NA

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

NCT05735691

Multiple Sclerosis

RECRUITING NA

Wearable Technology to Assess Gait Function in SMA and DMD

NCT04193085

Spinal Muscular Atrophy Type 3 Duchenne Muscular Dystrophy

COMPLETED

Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis

NCT03536299

Multiple Sclerosis Gait Disorders, Neurologic Cognitive Impairment

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-site observational longitudinal study to validate an MS Gait Remote Capture and Analysis system for home-based and repeatable gait assessments. The investigators will recruit 30 participants who will have an in-person baseline visit (informed consent, standard gait assessment, sensor-based gait assessment, self-reported questionnaires), followed by three remote visits (sensor-based gait assessment, SUS questionnaire \[last remote visit only\]).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults with MS

Participants will complete an in-clinic visit (self-reported outcome of MS disability, a standard walking clinical evaluation, and a sensor-based gait evaluation) and 3 remote supervised self-administered gait assessments using the MS-GRCA system.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 18-70 years old (inclusive)
* Confirmed diagnosis of MS (any MS subtypes, Relapsing Remitting \[RR\], Primary Progressive \[PP\], or Secondary Progressive \[SP\])
* PDSS score from 0 to 5
* Stable and continuous access to internet at home
* Adequate home facilities (enough space, quiet and distraction free area)
* Ability to provide informed consent.

Exclusion Criteria

* Below average estimated premorbid cognitive functioning (based on WRAT-4 reading recognition standard z-score \< 85).
* Presence of severe cognitive impairment (based on SDMT age normative z-score \< -3.0).
* Presence of primary neurological disorders other than MS or primary psychiatric disorder that would influence ability to complete assessments.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes